|
AU2016200507A1
|
|
Treatment of cancer
|
|
US2016082111A1
|
|
Cyclodextrin-based polymers for therapeutic delivery
|
|
AU2015204279A1
|
|
Cyclodextrin-based polymers for therapeutic delivery
|
|
WO2015184326A1
|
|
Conjugates, particles, compositions, and related methods
|
|
WO2015057847A1
|
|
Conjugates, particles, compositions, and related methods
|
|
US2017065723A1
|
|
Treatment of cancer
|
|
US2014378414A1
|
|
Cyclodextrin-based polymers for therapeutic delivery
|
|
AU2014273983A1
|
|
Cyclodextrin-based polymers for the therapeutic delivery
|
|
WO2014055913A1
|
|
Treatment of cancer
|
|
WO2014055493A1
|
|
Methods and systems for polymer precipitation and generation of particles
|
|
WO2013158710A2
|
|
Methods and systems for polymer precipitation and generation of particles
|
|
AU2013204389A1
|
|
Conjugates, particles, compositions, and related methods
|
|
AU2013204984A1
|
|
Cyclodextrin-based polymers for therapeutics delivery
|
|
US2014037573A1
|
|
Conjugates, particles, compositions, and related methods
|
|
WO2013126331A1
|
|
Methods of separating nucleic acid-polymer conjugates
|
|
WO2013116200A1
|
|
Cyclodextrin-based polymers for therapeutic delivery
|
|
WO2013115966A1
|
|
Cyclodextrin-based polymers for therapeutic delivery
|
|
EP2811980A1
|
|
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
AU2012247051A1
|
|
Cyclodextrin-based polymers for therapeutics delivery
|
|
WO2013025337A1
|
|
Cyclodextrin-based polymers for therapeutic delivery
|
